
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Veeva Systems announced that Debiopharm International SA, part of Swiss-based biopharmaceutical company Debiopharm Group™, has selected Veeva Vault eTMF for eTMF collaboration on a single, cloud-based application. Previously, Debiopharm’s external partners were unable to access the company's on-premise eTMF, so CROs used their own systems and transferred documents periodically.
Read the full release






